HOME >> MEDICINE >> NEWS
Novel antibiotic provides rapid relief from symptoms of tonsillitis/pharyngitis, study shows

Ketek (telithromycin), a novel compound from a new family of antibiotics, administered once daily for five days to patients suffering from tonsillitis/pharyngitis, provided equivalent clinical and bacteriological outcomes as those observed in patients receiving a 10-day course of treatment with penicillin V, a new study shows.

The more rapid symptom relief achieved with Ketek, the first antibiotic from the ketolide family to be developed for clinical use, may suggest a potential for a faster return to usual activities, and fewer days lost from work or school, for people with tonsillitis/pharyngitis resulting from group A b-haemoliytic streptococcus (GABHS) bacteria. GABHS is the most common bacterial cause of tonsillitis/pharyngitis.

The study results, reported today at the 11th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) meeting in Istanbul, Turkey, were among several scientific presentations involving Ketek.

"This is an important study as it demonstrates the clinical and bacteriological effectiveness and symptom relief of Ketek in treating what is a very common upper respiratory tract infection," said Dr. Joanne Chang, Aventis Pharma.

The double-blinded study enrolled 396 patients between the ages of 15 and 65 with clinical signs and symptoms of acute tonsillopharyngitis, and who either had a positive streptococcal A antigen test or a positive throat culture for GABHS. These patients were randomized (198 patients to each group) to receive either 800 mg once daily Ketek followed by placebo for five days, or penicillin V 500 mg three-times daily for 10 days. Clinical and bacteriological outcomes were assessed at post-therapy (days 16-21) and late post-therapy (days 38-45).

At the post-therapy visit, bacteriological outcome was satisfactory in 79.7 percent and 79.3 percent of patients, and clinical cure was achieved in 85.9 percent and 85.8 percent of patients in the Ketek (198 patients) and penicillin V (197
'"/>

Contact: Liz Rickard
elizabeth.rickard@ketchum.com
44-0-20-7611-3633
Ketchum
4-Apr-2001


Page: 1 2

Related medicine news :

1. Novel therapy tested in mice could chase away cat allergies
2. Novel antibiotic shows promise in shortening treatment duration of tuberculosis
3. Novel p53 gene-based therapy boosts immune system and reduces tumor size
4. Novel drugs help solve Gleevec resistance
5. Novel imaging technique shows abnormal brain anatomy in children with ADHD
6. Novel drug-antidote strategy provides greater control of drug action
7. Novel imaging technique shows lymph nodes, metastases in breast cancer without surgery
8. Novel delivery method for nutrients wins Kaye Innovation Award for Hebrew university students
9. Novel vitamin discovery offers clues for cancer chemotherapy and lipid disorders
10. Novel findings about neovessel formation
11. Novel MRI technique provides clear images of blood flow

Post Your Comments:
(Date:6/30/2015)... Los Angeles, CA (PRWEB) , ... June 30, 2015 , ... ... Reasons You Have Acne ,” listed five triggers that most people would not ... cloths, hair care products, and toothpaste. The primary causes of acne are ...
(Date:6/30/2015)... ... June 30, 2015 , ... After many requests from international ... here, http://www.express-glasses.com is proud to announce its collaboration with DHL for ... with DHL Express when calling or visiting the express glasses website. express glasses ...
(Date:6/30/2015)... ... June 30, 2015 , ... From the moment a ... wowed with the incredible care that they receive and the luxury in which they ... but now they are proud to offer the same experience, just better! , Their ...
(Date:6/30/2015)... ... June 30, 2015 , ... Allied Anesthesia physicians ... Fullerton division volunteered to help provide free outpatient procedures to some of Orange ... St. Jude Medical Center. , The event was coordinated by AccessOC, which ...
(Date:6/30/2015)... ... June 30, 2015 , ... CCAR is pleased to announce its expansion of ... Willimantic and Bridgeport. This month, staff member Jim Higgins left his role as ... is excited to take on this role of organizing peer recovery support available through ...
Breaking Medicine News(10 mins):Health News:A List of 5 Surprising Acne Triggers and the Latest Acne Treatment Options 2Health News:Eyeglasses Online - Express Glasses Announcing New International Shipping Using DHL 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 2Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 3Health News:NJ Top Dentist, Dr. Laurence C. Breiterman is Now Offering the WOW Factor at His Highly Regarded Dental Practice 4Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 2Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 3Health News:The Connecticut Community for Addiction Recovery takes Recovery Coaching to a new level 2
(Date:6/30/2015)... 30, 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... Annual Meeting of StockholdersWhen:Tuesday, June 30 at 5:10 p.m. ... Internet.  Simply log onto our website listed above.   ... the live event, a replay of the webcast will ... . ABOUT ISIS PHARMACEUTICALS, INC. ...
(Date:6/30/2015)... June 30, 2015 PharmaVentures is ... to Chip-Man Technologies Oy (CMT) on its divestment of ... relate to CMTs world leading capabilities in cellular imaging ... in a series of successful global deals in the ... Fintan Walton , CEO, PharmaVentures, commented: "PharmaVentures ...
(Date:6/29/2015)... 30, 2015 , Gerresheimer will sell ... and Gerresheimer enter into a 10-year-supply agreement for pharmaceutical ... EUR 196m debt-free Corning and Gerresheimer will ... glass packaging market Gerresheimer,s outlook for the financial ... disposal of the tubing business , In line ...
Breaking Medicine Technology:Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 2Webcast Alert: Corporate Presentation at the 2015 Isis Pharmaceuticals Annual Stockholder Meeting 3PharmaVentures Completes M&A Deal for Technology in the Stem Cell & Regenerative Medicine Sector 2Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 2Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 3
Cached News: